Turmeric and Curcumin: Comparing Extracts Without Confusing the Milligrams

What turmeric and curcumin are

Turmeric is the yellow spice made from the underground stem of Curcuma longa. Curcumin is one of its curcuminoids, the compounds behind much of the supplement research. A spoonful of spice, a concentrated extract and a curcumin phytosome are different preparations. A phytosome combines curcumin with phospholipids, a type of fat, to change its delivery.

Research extends beyond joint pain to depression, memory and ulcerative colitis, with different findings in each population. The distinction between preparations matters before choosing an amount. 1,500 mg of turmeric powder is not 1,500 mg of curcumin. Extract and delivery-system weights need their own explanation too.

Historical uses and the preparations behind them

Turmeric has been food, a coloring material and a medicine in several traditions. NCCIH describes^[1] Chinese, Indian—including Ayurvedic—Islamic and Thai uses for digestive complaints, joint problems and skin conditions, as well as cosmetic use and some Indian religious ceremonies.

The European Medicines Agency’s historical assessment^[2] makes the preparations more concrete: it describes Chinese preparations used by mouth or on the skin, and Ayurvedic and Siddha turmeric pastes applied to ulcers and scabies. Its European records include powdered underground stem and liquid preparations for digestive complaints.

What people take turmeric and curcumin for

Joint symptoms are a common reason to consider these products. The encouraging results come with uncertainty about which preparation helps, by how much and for how long. A positive study of a specific formulation does not imply the same results are achievable by using turmeric in your kitchen.

The U.S. National Center for Complementary and Integrative Health, or NCCIH, says the overall evidence remains insufficient for a definitive health-benefit conclusion. That cautious position coexists with positive short trials.

“Review pending” means our source assessment is incomplete, not that the studies found no effect.

When to ask a doctor before taking an extract

Discuss concentrated products if you have liver disease, unexplained abnormal liver tests or take prescription medicines. Products that increase curcumin absorption may change the safety question as well as the amount reaching the circulation. Piperine, a black-pepper constituent added to some products, also warrants a medicine review.

Stop the supplement and seek assessment if yellowing of the skin or eyes, dark urine or other signs of liver injury appear. Do not try to manage suspected injury by merely reducing the amount.

Amounts and timing

No recommended daily amount or official upper limit has been set by the National Academies. Research amounts must be read with the preparation: milligrams of spice, curcuminoid extract and a carrier-containing phytosome are different dose scales.

There is no established morning, evening or cycling rule that unifies these products. Follow the exact product's instructions and review the decision with your clinician when medicines or liver concerns are involved.

What to pay attention to on the label

There is no current product recommendation here. Choose a label that clearly distinguishes whole powder, extract, curcuminoids and any carrier-containing complex.

Which amount is curcumin?

A product may list turmeric powder, an extract and an extract's curcuminoid content separately. Read each line before adding anything. Multiplying an extract's weight by its curcuminoid percentage gives the amount of that whole group of compounds, not curcumin alone. Without a separate curcumin declaration, you cannot assume that group amount matches a study reporting curcumin alone. With a phytosome, the whole preparation includes its carrier, so the total weight is larger than its curcumin amount.

With roughly 3–5% curcuminoids, a 1,500 mg powder serving would supply approximately 45–75 mg curcuminoids.

Misleading labels

A large “turmeric equivalent” number

An equivalent plant weight may describe how much starting material was used. It is not automatically the weight of extract or curcumin you take. Compare the actual extract and standardized content.

A named trial attached to a different preparation

A product advertised as “clinically studied turmeric” may refer to research on another formulation. The shared plant name does not establish that the advertised product has any relationship to the one tested.

Absorption multiples presented as pain relief

A claim such as “29 times better absorbed” may come from blood measurements. It does not mean 29 times the symptom relief. A short absorption experiment cannot establish a long-term treatment result.

The much-quoted piperine exposure experiment used 2 g curcumin plus 20 mg piperine. It measured absorption, not symptom relief, and does not establish what another piperine amount would do.

Drawbacks and side effects

Body odor changes (user-reported). A commenter described a curry-like body odor^[7] after several weeks of taking curcumin and said it faded after stopping. This is an unconfirmed personal account, so the cause, frequency and relationship to dose remain unknown.

The Drug-Induced Liver Injury Network series cannot tell us the frequency of injury because it does not count all the people who used these supplements. Piperine was found in three of seven tested products, so it was not present in every tested case.

Turmeric during pregnancy and breastfeeding

NCCIH warns that turmeric supplements may be unsafe during pregnancy. Safety of amounts above normal food use during breastfeeding is poorly established. Women should distinguish culinary seasoning from concentrated supplements and discuss the latter with their maternity clinician.

The science behind turmeric and curcumin

Traditional digestion use and modern indigestion trials

The European Medicines Agency monograph^[6] recognizes specified preparations for fullness, slow digestion and gas on the basis of long-standing use.

In Yongwatana's 2022 trial^[8], 132 adults with functional dyspepsia—persistent indigestion without a structural explanation—were assigned to curcumin, omeprazole or placebo. Four-week symptom improvements favored curcumin over placebo. The comparison did not prove equivalence to omeprazole. A different trial^[9] found no added symptom benefit when curcumin accompanied famotidine, another acid-reducing medicine.

These findings leave the digestive benefit unsettled across treatments.

Joint-pain benefit remains uncertain in size

Daily's 2016 review reported better pain and function scores with mixed extracts than placebo, but its pooled figures need reconciliation before we can rely on the estimated benefit. The review's graphs and table disagree about which treatment groups were compared. Its combined function estimate also mixes different scoring scales and counts some participants' results more than once. The included studies were not all osteoarthritis trials. The review did not find a clear pain-score difference against pain medicines, and its authors considered the evidence insufficient for a definitive conclusion. James Daily was president of a supplement manufacturer.

Belcaro's study following 50 patients reported larger improvements with usual care plus 1,000 mg/day Meriva, containing about 200 mg curcumin. There was no blinded placebo comparison, and two authors were managers at Meriva manufacturer Indena. Selection, expectations and usual care could contribute to the changes.

Two direct comparisons with anti-inflammatory pain medicines add a different kind of evidence. A Thai trial^[10] randomized 367 adults with knee osteoarthritis to an ethanolic turmeric extract or ibuprofen for four weeks. Its capsule schedule supplied 1,500 mg/day of curcuminoids, compared with 1,200 mg/day ibuprofen. Among 331 completers, the extract met the study’s predefined margin for being no more than 0.5 point worse on 0–10 pain, function and overall symptom scales. Stiffness did not meet that margin. This was a short comparison of one extract, analyzed in people who completed treatment.

In Shep’s 28-day study^[11], BCM-95 at 500 mg three times daily was compared with diclofenac at 50 mg twice daily. The pain analysis included 139 participants; both groups finished at 2.20 on a 0–10 pain scale. Participants and clinicians knew which treatment was given, and the study did not set an equivalence margin. Its lack of a significant difference therefore cannot show that the treatments are interchangeable.

The registry, direct medicine comparisons and uncertain review estimate answer different questions. They leave the benefit of specific preparations against placebo unresolved.

Absorption studies

Cuomo studied nine volunteers and reported roughly 29-fold greater total curcuminoid exposure with Meriva than an unformulated mixture. This was a blood-measurement result, not a test of symptom relief.

Depression: small trials and important uncertainties

Curcumin has been tested in people with diagnosed major depression, including as an addition to antidepressants. This is a different question from whether turmeric makes someone without depression feel happier or more energetic.

In Lopresti's 2014 trial^[12], 56 adults received 500 mg curcumin twice daily or placebo for eight weeks. Both groups improved during the first four weeks. Curcumin had an advantage on self-rated depression scores during weeks four to eight.

A 2017 study^[13] allocated 123 adults to placebo, curcumin at 250 or 500 mg twice daily, or the lower curcumin amount plus 15 mg saffron twice daily for 12 weeks. The three active groups, analyzed together, improved more than placebo on depression and anxiety ratings. The active regimens did not differ significantly from one another. This supports further study.

In a separate 65-person trial adding curcumin to antidepressants^[14], curcumin increased from 500 to 1,500 mg/day during a 12-week treatment period. Depression ratings favored curcumin at week 12 and at the week-16 follow-up.

The trials described here provide preliminary findings. The 2017 pooled result does not prove that each regimen works; this account does not resolve the wider, contradictory evidence. Small samples, variable preparations and short follow-up prevent a dependable antidepressant claim. Discuss any proposed addition to depression treatment with the prescriber, including the preparation and liver risks.

Memory in adults without dementia

The negative Alzheimer trial below is not the only human memory study. Trials in adults without dementia ask a different question: whether performance on memory or attention tests improves.

A 12-month Biocurcumax study^[15] tested cognitive aging. Its analysis of 96 older adults tested 1,500 mg/day against placebo. A difference on a broad cognitive screening test was driven by a temporary decline in the placebo group at six months. Other cognitive and clinical measurements did not differ between groups.

No clinical benefit in the Alzheimer trial

Ringman's placebo-controlled study tested unformulated C3 Complex at 2 or 4 g/day for 24 weeks in mild-to-moderate Alzheimer disease. Clinical outcomes and measured disease markers did not improve. Low exposure does not establish that an enhanced formulation would work; that would require another clinical test.

The open question is whether a specific preparation produces a meaningful, independently repeated clinical benefit with sufficiently measured liver safety. Better absorption alone cannot settle it.

Ulcerative colitis: an addition to existing treatment

Ulcerative colitis is an inflammatory disease of the colon. Curcumin trials have tested it alongside prescribed treatment, with different findings for symptom scores and remission, when disease activity becomes low or absent.

In Sadeghi’s trial^[16], 70 patients with mild-to-moderate disease were assigned to a curcumin supplement reported as 1,500 mg/day or placebo for eight weeks, alongside drug therapy. Disease-activity scores improved more with curcumin than placebo. Quality-of-life scores also improved more.

A different trial by Kedia^[17] tested purified curcumin at 150 mg three times daily—450 mg/day—or placebo, both with mesalamine at 2.4 g/day for eight weeks. Of 62 randomized patients, 41 completed treatment. Counting everyone randomized, remission occurred in 9 of 29 curcumin patients and 9 of 33 placebo patients. The difference was not statistically significant, and the estimate was imprecise. Clinical response and healing seen during bowel examination did not differ significantly either.

These trials differ in reported amounts and measured outcomes, so they do not establish that increasing the dose produces remission. Other studies examine prevention of relapse after remission, enhanced formulations, or a combination of curcumin with the herb QingDai. Those are separate treatment questions, and assessment of that wider evidence remains unfinished. Any proposed addition belongs in the treatment discussion with your gastroenterologist; the studied amounts are not a replacement for prescribed care.

Exercise soreness

In a small downhill-running trial^[18], 20 healthy, moderately active men were assigned to Meriva or placebo. The regimen was 1 g of the phytosome twice daily, supplying about 400 mg/day of curcumin, starting 48 hours before exercise and continuing through the following day. Nineteen men completed the study.

Overall leg-pain scores were lower with Meriva but did not differ significantly from placebo. Pain in the front of the thighs and selected MRI measures favored Meriva; most blood markers and muscle-biopsy findings did not. The small study tested many outcomes, some investigators were unblinded, and authors had manufacturer relationships. It offers a preliminary, mixed account of recovery after one exercise session.

Curcumin taken with iron

An acute study in healthy adults with normal iron stores^[19] tested one 500 mg HydroCurc capsule taken an hour after ferrous sulfate supplying either 18 or 65 mg of elemental iron. HydroCurc’s weight includes its delivery system; it is not 500 mg of pure curcumin.

At three hours, the rise in blood iron did not differ significantly between curcumin and placebo at either iron dose. This short test does not answer whether repeated use, a different preparation or turmeric eaten in a meal changes iron status. Research on those situations remains under assessment. The trial’s funder helped design the study.

What you may have heard on podcasts

Andy Galpin discussed 500 mg curcumin three times daily in a recovery context on Huberman Lab on February 22, 2023. He did not name the preparation or trial supporting that amount. His 1,500 mg curcumin statement cannot be compared directly with 1,500 mg root powder or 1,000 mg of a phytosome.

In the same episode, Andrew Huberman described a personal reduction in libido and drive that he associated with curcumin and his sensitivity to hormone changes.

Labs

When liver injury is suspected, liver blood tests^[20] help assess possible harm. Tell the clinician the exact product, preparation, amount and recent use, alongside your symptoms and other medicines. Normal results cannot predict future safety.

The bottom line

Some curcumin preparations may improve joint pain, but the size of that benefit remains uncertain. The small depression trials described here reported symptom improvements, but do not establish a dependable antidepressant benefit. The cognitive-aging study discussed here does not establish sustained protection, and an Alzheimer treatment trial was negative. Ulcerative-colitis trials have found both symptom improvement and no remission advantage when curcumin was added to medication; the wider evidence remains under assessment. The “anti-inflammatory” label is too broad to predict these different outcomes.

Better absorption is not automatically a better clinical outcome and can also change the safety question. Digestive effects, liver concerns and medicines are worth weighing against the size of the possible benefit.

Help us improve this article

Spotted an error or found a source we should consider? Tell us which part of this article needs another look and include a link if you have one. Please leave out personal health details and lab results; we can’t answer individual medical questions.

Your name

Email address

What would you like to share?Select a topicCorrectionSource or research suggestionArticle requestAccessibility issueBusiness inquirySomething else

Your message

Continue to email →Email us directly